---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-134570"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T01:23:39.507473+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# STERIS appoints Esther Alegria to Board of Directors effective May 3, 2023

## Summary
- Board size increased to ten members; Dr. Alegria, age 64, appointed immediately.
- She is Founder & CEO of APIE Therapeutics; previously SVP Global Manufacturing at Biogen.
- Prorated director fee of $74,220 payable in restricted stock units for remainder of 2022-23 term.
- Also serves on AVID Bioservices (NASDAQ: CDMO) board and its audit and governance committees.

## SEC filing metadata
- accession: 0001193125-23-134570
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/0001193125-23-134570-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/d287600d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-134570
- JSON: https://secwatch.observer/filing/0001193125-23-134570.json
- Plain text: https://secwatch.observer/filing/0001193125-23-134570.txt

## Key facts
- Executive change
  Esther Alegria was elected as Director at STERIS plc.
  - Action: elected
  - Role: Director
  source text: The Board of Directors (the “Board”) of STERIS plc (the “Company”) increased its size from nine to ten members on May 3, 2023, and elected Dr. Esther Alegria to serve as a director effective as of that date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/0001193125-23-134570-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.